Rockefeller Capital Management
ACIU icon

Rockefeller Capital Management’s AC Immune ACIU Stock Holding History

Rockefeller Capital Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38K Hold
1,000
– – ﹤0.01% 4392
2026
Q1 		$2.75K Hold
1,000
– – ﹤0.01% 4358
2025
Q4 		$3.14K Hold
1,000
– – ﹤0.01% 4205
2025
Q3 		$2.89K Buy
+1,000
New +$2.26K ﹤0.01% 4019

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Rockefeller Capital Management's ACIU Position: Q2 2026 in Review

Rockefeller Capital Management held its AC Immune (ACIU) position steady in Q2 2026 at 1,000 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #4392.

Rockefeller Capital Management first reported a position in ACIU in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.14K in Q4 2025. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Rockefeller Capital Management held 1,000 shares of AC Immune worth $2.38K as of Q2 2026.
  • Rockefeller Capital Management left its AC Immune share count unchanged in Q2 2026.
  • AC Immune made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4392 holding.
  • Rockefeller Capital Management first reported a position in AC Immune in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's AC Immune position peaked at $3.14K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.